Publisher
Springer International Publishing
Reference60 articles.
1. Abgral R, Le Roux PY, Keromnes N et al (2012) Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging 39(12):1839–1847
2. Abgral R, Querellou S, Potard G et al (2009) Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 50(1):24–29
3. Abouzied MM, Fathala A, Alsugair A et al (2017) Role of fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of head and neck carcinoma. World J Nucl Med 16(4):257–265
4. Aoki J, Watanabe H, Shinozaki T et al (2001) FDG PET of primary benign and malignant bone tumors: standardized uptake values in 52 lesions. Radiology 219:774–777
5. Beheshti M, Pirich C, Langsteger W (2010) Conventional Tc-99m-based bone scan versus fluoride positron emission tomography combined with computed tomography in the assessment of bone metastases in prostate cancer patients. Imaging Decisions MRI 13:67–129